Dr. Dandachi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Hospital Dr
Columbia, MO 65212Phone+1 573-882-3107Fax+1 573-884-5790
Summary
- Dr. Dima Dandachi is an internist in Columbia, MO and is affiliated with University of Missouri Health Care. She received her medical degree from Beirut Arab University Faculty of Medicine and has been in practice for 5 years. She also speaks multiple languages, including Arabic. She specializes in infectious disease.
Education & Training
The University of TexasMPH, Health Care Management , 2017 - 2020
Baylor College of MedicineFellowship, Infectious Disease, 2016 - 2018
Ascension Illinois/Saint FrancisChief Residency, Internal Medicine, 2015 - 2016- Ascension Illinois/Saint FrancisResidency, Internal Medicine, 2012 - 2015
Beirut Arab University Faculty of MedicineClass of 2006
Certifications & Licensure
MO State Medical License 2018 - 2026
IL State Medical License 2012 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Polly Sparks Turner, Endowed Scholarship in Community Health The University of Texas, 2017
Clinical Trials
- Accelerated ART Initiation for PWHIV Who Are Out of Care Start of enrollment: 2024 Apr 29
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Revival of a Beast: The Challenges Facing the Management and Control of Syphilis in Missouri from 2000 to 2024.Hilal Abdessamad, Wassim Jamaleddine, Christian Rojas-Moreno, Dima Dandachi
Missouri Medicine. 2024-12-19 - EHR-based Case Identification of Pediatric Long COVID: A Report from the RECOVER EHR Cohort.Morgan Botdorf, Kimberley Dickinson, Vitaly Lorman, Hanieh Razzaghi, Nicole Marchesani
Medrxiv. 2024-08-26 - 2 citationsInfliximab Concentrations in Participants with Moderate to Severe COVID-19.Stephen J Balevic, Dima Dandachi, Danielle Dixon, Richard M W Hoetelmans, Sam Bozzette
Journal of Clinical Pharmacology. 2024-04-01
Press Mentions
MU School of Medicine and MU Health Enroll 103 in Novavax Vaccine TrialApril 15th, 2021- MU School of Medicine Completes Enrollment in Large-Scale COVID-19 Vaccine TrialApril 15th, 2021
COVID-19 Convalescent Plasma: From Donation to Treatment – A Systematic Review & Single Center ExperienceFebruary 13th, 2021- Join now to see all
Committees
- University of Missouri, Infection Control Committee 2018 - Present
Professional Memberships
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
